iStat Biomedical Co. commercializes the Cervi-M®, ZNF582 DNA, and the Oral-M® assay, which are based on the methylation analysis of genes ZNF582 and PAX1. These genes are highly methylated in cervical and oral cancers, as described by Lin et al. (2014) and Chang et al. (2015). This evidence concerns the gene ZNF582 and lip and oral cavity carcinoma.